Article
Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.
Arthritis research & therapy - 10 Jul 2014
García-Bermúdez Mercedes, López-Mejías Raquel, Genre Fernanda, Castañeda Santos, Llorca Javier, González-Juanatey Carlos, Corrales Alfonso, Ubilla Begoña, Miranda-Filloy José A, Pina Trinitario, Gómez-Vaquero Carmen, Rodríguez-Rodríguez Luis, Fernández-Gutiérrez Benjamín, Balsa Alejandro, Pascual-Salcedo Dora, López-Longo Francisco J, Carreira Patricia, Blanco Ricardo, Martín Javier, González-Gay Miguel A
Abstract excerpt
INTRODUCTION: Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis and increased cardiovascular (CV) disease risk. Interferon regulatory factor 5 (IRF5) is a regulator of type I interferon induction. Recently, researchers have described an association between multiple single-nucleotide polymorphisms of the IRF5 gene and some rheumatic disorders. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
